Harding, J. J., Yang, T., Chen, Y., Feng, Y., Yen, C., Ho, C., Huang, W., El Dika, I., Akce, M., Tan, B., Cohen, S. A., Meyer, T., Sarker, D., Lee, D., Ryoo, B., Lim, H. Y., Johnston, A., Bomalaski, J. S., O'Reilly, E. M., Qin, S., & Abou‐Alfa, G. K. (2021). assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study. Cancer, 127(24), 4585–4593. http://access.bl.uk/ark:/81055/vdc_100147201968.0x000064